18 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Molina (MOH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2222933/molina-moh-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2222933 Feb 07, 2024 - Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage https://www.zacks.com/commentary/2224560/3-hmo-stocks-in-focus-despite-high-tech-costs-nursing-shortage?cid=CS-ZC-FT-industry_outlook-2224560 Feb 12, 2024 - Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers https://www.zacks.com/stock/news/2236169/the-joint-jynt-to-report-q4-earnings-here-are-the-key-drivers?cid=CS-ZC-FT-analyst_blog|earnings_preview-2236169 Mar 05, 2024 - The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings https://www.zacks.com/stock/news/2245867/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245867 Mar 26, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Centene (CNC) Wins Medicaid Contract to Better Serve Michigan https://www.zacks.com/stock/news/2254020/centene-cnc-wins-medicaid-contract-to-better-serve-michigan?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254020 Apr 11, 2024 - Centene's (CNC) Meridian secures a contract from the Michigan Department of Health and Human Services, which gives it the opportunity to better serve the health needs of the state's Medicaid members.
Molina (MOH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2261721/molina-moh-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2261721 Apr 24, 2024 - The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership https://www.zacks.com/stock/news/2262684/molina-healthcare-moh-q1-earnings-beat-on-growing-membership?cid=CS-ZC-FT-analyst_blog|earnings_article-2262684 Apr 25, 2024 - Molina Healthcare's (MOH) Q1 results reflect strong premium revenue growth. It continues to estimate adjusted EPS at a minimum of $23.50 for 2024.
Universal Health (UHS) Q1 Earnings Beat on Rising Patient Days https://www.zacks.com/stock/news/2262619/universal-health-uhs-q1-earnings-beat-on-rising-patient-days?cid=CS-ZC-FT-analyst_blog|earnings_article-2262619 Apr 25, 2024 - Universal Health's (UHS) first-quarter results benefit from improved patient days in both segments. However, higher expenses partially offset the positives.
Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked https://www.zacks.com/stock/news/2263590/centene-cnc-q1-earnings-beat-on-premiums-24-eps-view-hiked?cid=CS-ZC-FT-analyst_blog|earnings_article-2263590 Apr 26, 2024 - Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.
Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View https://www.zacks.com/stock/news/2266339/tenet-healthcare-thc-beats-on-q1-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2266339 May 01, 2024 - Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.

Pages: 12

Page 1